Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HC30
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 68 | 72 | PF00656 | 0.582 |
CLV_C14_Caspase3-7 | 91 | 95 | PF00656 | 0.436 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.380 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.400 |
DOC_CYCLIN_RxL_1 | 5 | 14 | PF00134 | 0.332 |
DOC_PP2B_LxvP_1 | 96 | 99 | PF13499 | 0.306 |
DOC_PP4_FxxP_1 | 112 | 115 | PF00568 | 0.470 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.670 |
DOC_USP7_UBL2_3 | 58 | 62 | PF12436 | 0.482 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.488 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.450 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.532 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.467 |
LIG_LIR_Apic_2 | 110 | 115 | PF02991 | 0.277 |
LIG_LIR_Gen_1 | 102 | 107 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 102 | 106 | PF02991 | 0.478 |
LIG_PCNA_yPIPBox_3 | 6 | 19 | PF02747 | 0.320 |
LIG_SH2_CRK | 103 | 107 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.315 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.336 |
LIG_SH3_5 | 99 | 103 | PF00018 | 0.370 |
MOD_CDC14_SPxK_1 | 80 | 83 | PF00782 | 0.485 |
MOD_CDK_SPxK_1 | 77 | 83 | PF00069 | 0.488 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.438 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.471 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.460 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.508 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.448 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.465 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.552 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.612 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.478 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.417 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.538 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.515 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.464 |
MOD_N-GLC_1 | 75 | 80 | PF02516 | 0.548 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.597 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.459 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.464 |
MOD_OFUCOSY | 104 | 111 | PF10250 | 0.268 |
MOD_PIKK_1 | 48 | 54 | PF00454 | 0.381 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.545 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.353 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.488 |
MOD_SUMO_rev_2 | 43 | 49 | PF00179 | 0.387 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.446 |
TRG_ER_diArg_1 | 130 | 133 | PF00400 | 0.429 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HU38 | Leptomonas seymouri | 39% | 100% |
A0A3Q8IAH7 | Leishmania donovani | 69% | 100% |
A0A422N8B7 | Trypanosoma rangeli | 30% | 100% |
A4HZH3 | Leishmania infantum | 68% | 100% |
D0A101 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 68% |
E9AVG3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 66% | 100% |
Q4QC16 | Leishmania major | 67% | 100% |